• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Express Scripts

Express Scripts

Express Scripts Holding Co ESRX

Last Price$69.61Day Change (%)-2.01%
Open Price$70.63Day Change ($)-1.43
Day Range69.54–70.6352-Week Range65.55–89.20

As of Fri 10/21/2016 5:00:00 PM | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  1. Insulin List-Prices Climb Even as Drugmakers' Share Stays Flat

    Insulin List-Prices Climb Even as Drugmakers' Share Stays Flat

  2. Morningstar Minute: 3 Pillars to Express Scripts' Wide Moat

    Pharmacy benefits manager Express Scripts is attractively priced given its ability to fend off competitors for years to come.

  3. Express Scripts Well Positioned for New Health-Care Order

    The wide-moat pharmacy benefit manager is still undervalued.

  4. Express Scripts : One of the Widest Moats in Health Care

    Investors can pick up shares of this pharmacy benefit manager, which enjoys enormous supplier-pricing and scale advantages, at a significant discount.

  5. Berkshire Likes Express Scripts --and So Do We

    The wide-moat pharmacy benefit manager--which is currently rated 4 stars by Morningstar--was Berkshire's only new money purchase during the third quarter.

  6. Market Overreaction Makes Express Scripts Even More Attractive

    Misunderstanding on private health insurance exchanges could mean opportunity for investors.

  7. Will the Election Affect Earnings?

    If Americans sweep Democrats into office, these healthcare proposals could get a shot in the arm. Here’s how they would have an impact on earnings.

  8. A Rare, Wide-Moat Find in a Market With Few Values

    Investors concerned with Express Scripts' integration of Medco are overlooking the firm's long-term potential to benefit from an increased focus on health-care cost-cutting, says Morningstar StockInvestor editor Matt Coffina.

  9. Fixed Income Roadmap: Where Next For Bonds?

    Express Scripts ESRX reported first-quarter results that beat our expectations. The company also increased its earnings-per-share guidance for the year, but more importantly to us, Express Scripts expects higher cash flow from operations in 2007 than it did previously. We're reviewing our model in ...

Upcoming Events

©2014 Morningstar Advisor. All right reserved.